BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) exclusively infects humans, causing significant numbers of upper respiratory tract infections. The goal of this study was to develop a safe experimental human model of NTHi nasopharyngeal colonization. METHODS: A novel streptomycin-resistant strain of NTHi was developed, and 15 subjects were inoculated in an adaptive-design phase I trial to rapidly identify colonizing doses of NTHi. Bayesian analysis was used to estimate the human colonizing dose 50 and 90 (HCD50 and HCD90, respectively). Side effects and immunological responses to whole-cell sialylated NTHi were measured. RESULTS: Nine subjects were colonized and tolerated colonization well. Immunological analyses demonstrated that 7 colonized subjects and 0 noncolonized subjects had a 4-fold rise in serum levels of immunoglobulin A, immunoglobulin M, or immunoglobulin G. Preexisting immunity to whole-cell NTHi did not predict success or failure of colonization. CONCLUSIONS: The statistical design incorporated a slow escalation to higher dose levels. HCD50 and HCD90 Bayesian estimates were identified as approximately 2000 and 150 000 colony-forming units, respectively; credible interval estimates were broad. This study provides a potential platform for early proof of concept studies for NTHi vaccines, as well as a way to evaluate bacterial factors associated with colonization.
BACKGROUND: Nontypeable Haemophilus influenzae (NTHi) exclusively infects humans, causing significant numbers of upper respiratory tract infections. The goal of this study was to develop a safe experimental human model of NTHi nasopharyngeal colonization. METHODS: A novel streptomycin-resistant strain of NTHi was developed, and 15 subjects were inoculated in an adaptive-design phase I trial to rapidly identify colonizing doses of NTHi. Bayesian analysis was used to estimate the human colonizing dose 50 and 90 (HCD50 and HCD90, respectively). Side effects and immunological responses to whole-cell sialylated NTHi were measured. RESULTS: Nine subjects were colonized and tolerated colonization well. Immunological analyses demonstrated that 7 colonized subjects and 0 noncolonized subjects had a 4-fold rise in serum levels of immunoglobulin A, immunoglobulin M, or immunoglobulin G. Preexisting immunity to whole-cell NTHi did not predict success or failure of colonization. CONCLUSIONS: The statistical design incorporated a slow escalation to higher dose levels. HCD50 and HCD90 Bayesian estimates were identified as approximately 2000 and 150 000 colony-forming units, respectively; credible interval estimates were broad. This study provides a potential platform for early proof of concept studies for NTHi vaccines, as well as a way to evaluate bacterial factors associated with colonization.
Authors: W E Swords; B A Buscher; K Ver Steeg Ii; A Preston; W A Nichols; J N Weiser; B W Gibson; M A Apicella Journal: Mol Microbiol Date: 2000-07 Impact factor: 3.501
Authors: R S Young; K R Fortney; V Gelfanova; C L Phillips; B P Katz; A F Hood; J L Latimer; R S Munson; E J Hansen; S M Spinola Journal: Infect Immun Date: 2001-03 Impact factor: 3.441
Authors: Patricia A Schachern; Vladimir Tsuprun; Beinan Wang; Michael A Apicella; Sebahattin Cureoglu; Michael M Paparella; Steven K Juhn Journal: Int J Pediatr Otorhinolaryngol Date: 2009-10-22 Impact factor: 1.675
Authors: Roman Prymula; Pascal Peeters; Viktor Chrobok; Pavla Kriz; Elena Novakova; Eva Kaliskova; Igor Kohl; Patricia Lommel; Jan Poolman; Jean-Paul Prieels; Lode Schuerman Journal: Lancet Date: 2006-03-04 Impact factor: 79.321
Authors: Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham Journal: Int J Pediatr Otorhinolaryngol Date: 2019-12-18 Impact factor: 1.675
Authors: Stephen R Thomas; Stephanie Leung; Katy Knox; Tom M A Wilkinson; Karl J Staples; Pascal Lestrate; Dominique Wauters; Andrew Gorringe; Stephen C Taylor Journal: BMC Microbiol Date: 2018-10-29 Impact factor: 3.605
Authors: Caitlyn M Granland; Naomi M Scott; Jean-Francois Lauzon-Joset; Jeroen D Langereis; Camilla de Gier; Katrien M J Sutherland; Sharon L Clark; Janessa L Pickering; Ruth B Thornton; Peter C Richmond; Deborah H Strickland; Lea-Ann S Kirkham Journal: Infect Immun Date: 2020-03-23 Impact factor: 3.441